Matthew Lindon

1.6k total citations
11 papers, 393 citations indexed

About

Matthew Lindon is a scholar working on Molecular Biology, Hematology and Organic Chemistry. According to data from OpenAlex, Matthew Lindon has authored 11 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Hematology and 1 paper in Organic Chemistry. Recurrent topics in Matthew Lindon's work include Protein Degradation and Inhibitors (6 papers), Multiple Myeloma Research and Treatments (4 papers) and Histone Deacetylase Inhibitors Research (3 papers). Matthew Lindon is often cited by papers focused on Protein Degradation and Inhibitors (6 papers), Multiple Myeloma Research and Treatments (4 papers) and Histone Deacetylase Inhibitors Research (3 papers). Matthew Lindon collaborates with scholars based in United Kingdom, United States and Germany. Matthew Lindon's co-authors include Chun‐wa Chung, Rab K. Prinjha, Paul Bamborough, Laurie Gordon, Paola Grandi, David F. Tough, Stephen J. Atkinson, Emmanuel H. Demont, Robert P. Law and Thilo Werner and has published in prestigious journals such as Journal of Medicinal Chemistry, British Journal of Pharmacology and Tetrahedron.

In The Last Decade

Matthew Lindon

11 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Lindon United Kingdom 9 292 107 80 58 24 11 393
Emma J. Jones United Kingdom 8 239 0.8× 67 0.6× 55 0.7× 39 0.7× 24 1.0× 15 311
Mairead Young United States 8 239 0.8× 79 0.7× 148 1.9× 86 1.5× 23 1.0× 8 399
Daniel P. Mould United Kingdom 8 388 1.3× 62 0.6× 54 0.7× 51 0.9× 11 0.5× 8 440
Sarah James United Kingdom 8 254 0.9× 29 0.3× 99 1.2× 29 0.5× 12 0.5× 10 372
Catherine Bardelle United Kingdom 12 237 0.8× 73 0.7× 47 0.6× 66 1.1× 39 1.6× 20 395
Marcel Scheepstra Netherlands 8 171 0.6× 26 0.2× 81 1.0× 55 0.9× 15 0.6× 11 263
Itsuro Shimada Japan 10 194 0.7× 161 1.5× 132 1.6× 88 1.5× 11 0.5× 19 490
Julia M. Wagner Germany 6 413 1.4× 22 0.2× 69 0.9× 154 2.7× 11 0.5× 7 523
Emma Fairweather United Kingdom 8 296 1.0× 48 0.4× 42 0.5× 121 2.1× 12 0.5× 12 394
Nirupama B. Soni United States 9 348 1.2× 21 0.2× 289 3.6× 110 1.9× 29 1.2× 11 593

Countries citing papers authored by Matthew Lindon

Since Specialization
Citations

This map shows the geographic impact of Matthew Lindon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Lindon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Lindon more than expected).

Fields of papers citing papers by Matthew Lindon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Lindon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Lindon. The network helps show where Matthew Lindon may publish in the future.

Co-authorship network of co-authors of Matthew Lindon

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Lindon. A scholar is included among the top collaborators of Matthew Lindon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Lindon. Matthew Lindon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Hirst, David J., Martín Brandt, Gordon Bruton, et al.. (2020). Structure-based optimisation of orally active & reversible MetAP-2 inhibitors maintaining a tight ‘molecular budget’. Bioorganic & Medicinal Chemistry Letters. 30(21). 127533–127533. 6 indexed citations
2.
Bamborough, Paul, Chun‐wa Chung, Peter D. Craggs, et al.. (2020). Application of Atypical Acetyl-lysine Methyl Mimetics in the Development of Selective Inhibitors of the Bromodomain-Containing Protein 7 (BRD7)/Bromodomain-Containing Protein 9 (BRD9) Bromodomains. Journal of Medicinal Chemistry. 63(11). 5816–5840. 27 indexed citations
3.
Law, Robert P., Stephen J. Atkinson, Paul Bamborough, et al.. (2018). Discovery of Tetrahydroquinoxalines as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for the Second Bromodomain. Journal of Medicinal Chemistry. 61(10). 4317–4334. 85 indexed citations
4.
Li, Jingjun, Jing Ma, Guofeng Meng, et al.. (2016). BET bromodomain inhibition promotes neurogenesis while inhibiting gliogenesis in neural progenitor cells. Stem Cell Research. 17(2). 212–221. 30 indexed citations
5.
Humphreys, P. G., Paul Bamborough, Chun‐wa Chung, et al.. (2016). Discovery of a Potent, Cell Penetrant, and Selective p300/CBP-Associated Factor (PCAF)/General Control Nonderepressible 5 (GCN5) Bromodomain Chemical Probe. Journal of Medicinal Chemistry. 60(2). 695–709. 70 indexed citations
6.
Lindon, Matthew, et al.. (2014). Summary of microcystin concentrations in Minnesota lakes. Lake and Reservoir Management. 30(3). 268–272. 9 indexed citations
7.
Tough, David F., Huw D. Lewis, Inmaculada Rioja, Matthew Lindon, & Rab K. Prinjha. (2014). Epigenetic pathway targets for the treatment of disease: accelerating progress in the development of pharmacological tools:IUPHARReview 11. British Journal of Pharmacology. 171(22). 4981–5010. 23 indexed citations
8.
Dittmann, Antje, Thilo Werner, Chun‐wa Chung, et al.. (2013). The Commonly Used PI3-Kinase Probe LY294002 Is an Inhibitor of BET Bromodomains. ACS Chemical Biology. 9(2). 495–502. 87 indexed citations
9.
Xu, Heng, Haibo Zhang, Yan Xu, et al.. (2012). Discovery of thiadiazole amides as potent, S1P3-sparing agonists of sphingosine-1-phosphate 1 (S1P1) receptor. Bioorganic & Medicinal Chemistry Letters. 22(7). 2456–2459. 3 indexed citations
10.
Henderson, Luke C., Matthew Lindon, & Michael C. Willis. (2010). Palladium catalyzed tandem alkenyl- and aryl-C–N bond formation: a cascade N-annulation route to 4-, 5-, 6- and 7-chloroindoles. Tetrahedron. 66(33). 6632–6638. 18 indexed citations
11.
Lewis, Stephen J., Adrian L. Smith, Joseph G. Neduvelil, et al.. (2004). A novel series of potent γ-secretase inhibitors based on a benzobicyclo[4.2.1]nonane core. Bioorganic & Medicinal Chemistry Letters. 15(2). 373–378. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emma J. Jones Breakdown of academic impact, for papers by Mairead Young Breakdown of academic impact, for papers by Daniel P. Mould Breakdown of academic impact, for papers by Sarah James Breakdown of academic impact, for papers by Catherine Bardelle Breakdown of academic impact, for papers by Marcel Scheepstra Breakdown of academic impact, for papers by Itsuro Shimada Breakdown of academic impact, for papers by Julia M. Wagner Breakdown of academic impact, for papers by Emma Fairweather Breakdown of academic impact, for papers by Nirupama B. Soni
Rankless by CCL
2026